• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别是肾输尿管切除术后上尿路上皮癌患者膀胱内复发的重要预测因子。

Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.

机构信息

Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.

出版信息

Urol Oncol. 2013 Aug;31(6):899-903. doi: 10.1016/j.urolonc.2011.06.014. Epub 2011 Aug 6.

DOI:10.1016/j.urolonc.2011.06.014
PMID:21824792
Abstract

OBJECTIVES

To retrospectively assess the significance of gender as a predictor of intravesical recurrence following nephroureterectomy for urothelial carcinoma of the upper urinary tract (UC-UUT).

MATERIALS AND METHODS

This study included 502 consecutive patients (360 male and 142 female) who were diagnosed as having clinically localized UC-UUT and underwent nephroureterectomy. Clinicopathologic outcomes of these patients were analyzed focusing on the impact of gender.

RESULTS

The incidence of intravesical recurrence in male patients (41.9%) was significantly greater than that in female patients (27.5%). Despite the lack of significant differences in cancer-specific and overall survivals with respect to gender, the intravesical recurrence-free survival in male patients was significantly worse than that in female patients. Of several parameters examined, univariate analysis identified gender, tumor site, and tumor focality as significant predictors of intravesical recurrence following nephroureterectomy. Of these, only gender and tumor site appeared to be independently associated with intravesical recurrence-free survival on multivariate analysis. Furthermore, there was a significant difference in intravesical recurrence-free survival according to positive numbers of these two independent factors; that is, intravesical recurrence occurred in 12 of 55 patients who were negative for both risk factors (21.8%), 96 of 280 positive for a single risk factor (34.3%), and 82 of 167 positive for both risk factors (49.1%).

CONCLUSIONS

The incidence of intravesical recurrence following nephroureterectomy for UC-UUT is comparatively high. Therefore, it would be potentially important to perform careful follow-up targeting intravesical recurrence for such patients, particularly for male patients and/or patients with tumor located at the ureter.

摘要

目的

回顾性评估性别作为预测上尿路上皮癌(UC-UUT)患者行肾输尿管切除术后膀胱内复发的指标的意义。

材料与方法

本研究纳入了 502 例临床局限性 UC-UUT 患者(360 例男性和 142 例女性),这些患者均接受了肾输尿管切除术。分析这些患者的临床病理结果,重点关注性别对这些结果的影响。

结果

男性患者(41.9%)的膀胱内复发发生率明显高于女性患者(27.5%)。尽管性别对癌症特异性和总体生存率没有显著影响,但男性患者的膀胱内无复发生存率明显差于女性患者。在检查的几个参数中,单因素分析确定了性别、肿瘤部位和肿瘤局灶性是肾输尿管切除术后膀胱内复发的显著预测因素。其中,仅性别和肿瘤部位在多因素分析中与膀胱内无复发生存率独立相关。此外,根据这两个独立因素的阳性数量,膀胱内无复发生存率存在显著差异;即,在这两个危险因素均为阴性的 55 例患者中有 12 例(21.8%)发生膀胱内复发,在仅单一危险因素阳性的 280 例患者中有 96 例(34.3%)发生膀胱内复发,在两个危险因素均为阳性的 167 例患者中有 82 例(49.1%)发生膀胱内复发。

结论

UC-UUT 患者行肾输尿管切除术后膀胱内复发的发生率相对较高。因此,对这些患者,尤其是男性患者和/或肿瘤位于输尿管的患者,进行膀胱内复发的密切随访可能非常重要。

相似文献

1
Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.性别是肾输尿管切除术后上尿路上皮癌患者膀胱内复发的重要预测因子。
Urol Oncol. 2013 Aug;31(6):899-903. doi: 10.1016/j.urolonc.2011.06.014. Epub 2011 Aug 6.
2
Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.在上尿路尿路上皮癌中 E-钙黏蛋白和 N-钙黏蛋白的表达谱与行肾输尿管切除术患者的疾病复发相关。
Urology. 2011 Dec;78(6):1443.e7-12. doi: 10.1016/j.urology.2011.07.1388. Epub 2011 Sep 15.
3
Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.上尿路尿路上皮癌腹腔镜肾输尿管切除术后初始膀胱内复发的独立预后因素。
Urol Oncol. 2014 Feb;32(2):146-52. doi: 10.1016/j.urolonc.2013.02.018. Epub 2013 Apr 28.
4
Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.肾盂输尿管癌根治术后发生的肌层浸润性膀胱癌。
Urol Oncol. 2013 Nov;31(8):1643-9. doi: 10.1016/j.urolonc.2012.04.014. Epub 2012 May 15.
5
Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.上尿路尿路上皮癌患者行肾输尿管切除术 后的膀胱癌。
Urol Oncol. 2011 Jul-Aug;29(4):383-7. doi: 10.1016/j.urolonc.2009.04.007. Epub 2009 Jun 24.
6
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.在上尿路尿路上皮癌患者接受肾输尿管切除术和膀胱袖状切除术治疗中,肿瘤位置与多灶性的影响:无围手术期化疗的同质系列。
BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.
7
Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.上尿路尿路上皮癌手术治疗后的膀胱内复发。
Urol Int. 2012;89(1):71-7. doi: 10.1159/000338644. Epub 2012 Jun 7.
8
Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.上尿路移行细胞癌手术治疗后膀胱内复发的危险因素。
Urology. 2008 Jan;71(1):123-7. doi: 10.1016/j.urology.2007.08.054.
9
Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.比较上尿路尿路上皮癌行节段性输尿管切除术与根治性肾输尿管切除术的肿瘤学结局:一项来自法国大型多中心研究的结果。
BJU Int. 2012 Oct;110(8):1134-41. doi: 10.1111/j.1464-410X.2012.10960.x. Epub 2012 Mar 6.
10
Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.肾输尿管切除术后上尿路尿路上皮癌的预后因素
Urol Int. 2012;88(2):225-31. doi: 10.1159/000335274. Epub 2012 Jan 11.

引用本文的文献

1
Differential Risk Factors for Early Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Carcinoma According to the History of Non-Muscle Invasive Bladder Cancer.根据非肌层浸润性膀胱癌病史,上尿路癌根治性肾输尿管切除术后早期膀胱内复发的差异危险因素
Int J Urol. 2025 May;32(5):567-574. doi: 10.1111/iju.70009. Epub 2025 Feb 13.
2
Clinicopathological characteristics, surgical treatments, and oncological outcomes of localized primary unifocal urothelial carcinoma involving the ureterovesical junction.累及输尿管膀胱连接处的局限性原发性单灶性尿路上皮癌的临床病理特征、手术治疗及肿瘤学结局
Int Urol Nephrol. 2024 Mar;56(3):941-955. doi: 10.1007/s11255-023-03838-0. Epub 2023 Oct 17.
3
Predictive value of gene methylation for second recurrence following surgical treatment of first bladder recurrence of a primary upper-tract urothelial carcinoma.
原发性上尿路尿路上皮癌首次膀胱复发手术治疗后基因甲基化对第二次复发的预测价值
Oncol Lett. 2018 Jun;15(6):9397-9405. doi: 10.3892/ol.2018.8498. Epub 2018 Apr 13.
4
Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.上尿路尿路上皮癌的预测模型和预后因素:文献综述
Transl Androl Urol. 2016 Oct;5(5):720-734. doi: 10.21037/tau.2016.09.07.
5
Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis.上尿路尿路上皮癌的人口统计学因素与预后的关联:一项系统评价和荟萃分析。
Oncotarget. 2017 Jan 31;8(5):7464-7476. doi: 10.18632/oncotarget.10708.
6
Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.上尿路尿路上皮癌的预后因素和预测工具:一项系统综述
World J Urol. 2017 Mar;35(3):337-353. doi: 10.1007/s00345-016-1826-2. Epub 2016 Apr 21.
7
Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators.采用根治性肾输尿管切除术加同侧膀胱袖口状切除术治疗的上尿路尿路上皮癌患者术后尿路上皮复发:与非尿路上皮复发及其他临床指标相比,对预后的影响最小。
Oncol Lett. 2013 Oct;6(4):1015-1020. doi: 10.3892/ol.2013.1485. Epub 2013 Jul 23.